Avadel to Present Data on Lumryz for Narcolepsy at SLEEP 2024
At SLEEP 2024, Avadel will present new data on Lumryz, the first extended-release, once-nightly formulation of sodium oxybate for narcolepsy.
Stay updated with breaking news from Michaelj Thorpy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At SLEEP 2024, Avadel will present new data on Lumryz, the first extended-release, once-nightly formulation of sodium oxybate for narcolepsy.
Topline data March 25, 2024 Forward Looking Statements & Safe Harbor Certain information contained in this...
Sleep specialists share practical tips on choosing medications that treat narcolepsy symptoms, including excessive daytime sleepiness and cataplexy.
With new narcolepsy drugs available, sleep specialists face the challenge of selecting the most suitable therapies for their patients.
Avadel Pharmaceuticals will present new data supporting the clinical profile for Lumryz for narcolepsy in 12 abstracts at SLEEP 2023.